ClinicalTrials.govpublic full text
Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
hiv infections, thymopentin, zalcitabine, didanosine, drug therapy, combination, zidovudine, stavudine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828641
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.